From: Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age | 1.046 (1.014–1.080) | 0.005 | 1.054 (1.015–1.095) | 0.007 |
Males | 1.355 (0.693–2.649) | 0.375 |  |  |
Small esophageal varices | 6.424 (2.660-15.513) | < 0.001 | 2.855 (1.139–7.158) | 0.025 |
ALT | 0.992 (0.985-1.000) | 0.054 | Â | Â |
AST | 0.994 (0.988–1.001) | 0.111 |  |  |
HBV DNA | 0.973 (0.836–1.133) | 0.727 |  |  |
qHBsAg (× 103) | 0.810 (0.672–0.977) | 0.027 | 0.883 (0.731–1.066) | 0.196 |
HBeAg positive | 1.044 (0.530–2.056) | 0.901 |  |  |
Received antiviral therapy | 1.213 (0.166–8.873) | 0.849 |  |  |
ALB | 0.899 (0.852–0.948) | < 0.001 | 1.032 (0.956–1.113) | 0.423 |
TBIL | 1.006 (0.992–1.020) | 0.431 |  |  |
Cr | 0.988 (0.964–1.013) | 0.346 |  |  |
PLT | 0.972 (0.963–0.981) | < 0.001 | 0.975 (0.962–0.988) | < 0.001 |
MELD score | 1.167 (1.064–1.281) | 0.001 | 0.946 (0.816–1.095) | 0.456 |
APRI | 0.988 (0.884–1.104) | 0.830 |  |  |
FIB-4 index | 1.131 (1.073–1.192) | < 0.001 | 0.929 (0.803–1.075) | 0.322 |
HA | 1.000 (1.000-1.001) | 0.621 | Â | Â |
LN | 1.016 (1.009–1.022) | < 0.001 | 1.012 (1.002–1.022) | 0.015 |
CIV | 1.007 (1.004–1.009) | < 0.001 | 1.005 (1.001–1.008) | 0.024 |
PIIINP | 1.018 (0.980–1.057) | 0.362 |  |  |